Big Moving Stock keep track of the biggest moving stocks in the market.


Nasdaq: GOOG NFLX BIIB AMZN IBB TSLA WYNN ILMN ALXN CHTR Z SLXP AMGN GMCR COST PCYC FFIV WDC SSYS
Nyse: ACT PXD V LNKD MCK IVV IBM GS SPG LMT AGN FDX TWC WHR MMM CMI XEC CXO APD CVX
New Highs: EXPE BYI CYH SPR X IDIX SCI

The Hot Industries

Biotechnology 1
Personal Services 1
Steel & Iron 1

The Hot Sectors

Services 3
Healthcare 1
Industrial Goods 1

AMRN Stock Chart


AMRN
Analyze

Sector:

Healthcare
Daily

Industry:

Drug Manufacturers - Other
Weekly

Employees:

185
Monthly

Website:

http://www.amarincorp.com

AMRN Amarin Corporation plc

Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases in the United States. It develops products in the areas of lipid science and therapeutic benefits of polyunsaturated fatty acids. The company markets Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It is also developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is based in Dublin, Ireland.

favicon

Stock Market Today: Dow Turns Negative for the Year as Earnings Gloom Sets In

31 Jul 2014, 1:31 pmNEW YORK (TheStreet) -- U.S. stock markets plummeted on volatile trading Thursday as mixed earnings reports, concerns about the health of the European economy and financial sector and the wait for Friday's big nonfarm payrolls report rocked the global markets. Amid the commotion, the bio-therapeutic drugs group was sparkling as Amarin flew 13.21%. The late-stage biopharmaceutical firm garnered a ...
favicon

Amarin Moves Higher On Speculation Of Special Protocol Assessment

31 Jul 2014, 10:01 amAmarin (NASDAQ: AMRN ) moved higher Thursday following upbeat biotech commentary from TheStreet.com's Adam Feuerstein. Feuerstein mentioned that Amarin, “is expected to hear soon on an appeal to a top ...
favicon

Amarin Shocker: There's a Reason to be Bullish Right Now

31 Jul 2014, 7:29 amBOSTON (TheStreet) -- It might be time to get bullish on Amarin .You're not hallucinating. This longtime Amarin bear believes there's now a compelling argument for going long the stock or its options -- if only for a speculative trade. The idea of being long Amarin seemed nutty when the idea was pitched to me by a source at a healthcare investment bank. But then I thought more about the Amarin ...
favicon

Press Release

23 Jul 2014, 4:11 amMENLO PARK Calif. July 23 2014 MENLO PARK Calif. July 23 2014 /PRNewswire/ -- Sofinnova Ventures a Menlo Park based investment firm today announced the closing of Sofinnova Venture Partners IX L.P. at the hard cap of $500 million and in excess of the initial fund target of $425 million.
favicon

Sofinnova Raises $500 Million Biotech Venture Fund

23 Jul 2014, 4:00 amMENLO PARK, Calif., July 23, 2014 /PRNewswire/ -- Sofinnova Ventures, a Menlo Park based investment firm, today announced the closing of Sofinnova Venture Partners IX, L.P. at the hard cap of $500 million ...
favicon

Shire Retreats for Second Day Since Abbvie's Revised Bid as European ADRs Decline; Portugal Telecom Gains

16 Jul 2014, 11:47 amShire Retreats for Second Day Since Abbvie's Revised Bid as European ADRs Decline; Portugal Telecom Gains